Related Experiment Video
Updated: Aug 10, 2026

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c
Published on: June 29, 2011
Cyclin dependent kinase inhibitors prevent apoptosis of postmitotic mouse motoneurons
A Appert-Collin1, B Hugel, R Levy
1Université Louis Pasteur, Faculté de Pharmacie, UMR7175-LC1, BP 24, F-67401 Illkirch Cedex, France.
Abstract:
Recent evidence suggests that apoptosis in post-mitotic neurons involves an aborted attempt of cells to re-enter the cell cycle which is characterized by increased expression of cyclins, such as cyclin D1, prior to death. However, such cyclins activation prior to apoptotic cell death remains controversial. Many neurological disorders are characterized by neuronal loss, particularly amyotrophic lateral sclerosis (ALS). ALS is a motoneuronal degenerative condition in which motoneuron loss could be due to an inappropriate return of these cells in the cell cycle. In the present study, we observed that deprivation of neurotrophic factor in purified motoneuron cultures induces an apoptotic pathway. After neurotrophic factor withdrawal, DAPI (4,6-diamidin-2-phenylindol dichlorohydrate) staining revealed the presence of nuclear condensation, DNA fragmentation, and perinuclear apoptotic body. Similarly, release of apoptotic microparticles and activation of caspases-3 and -9 were observed within the first hours following neurotrophic factor withdrawal. Next, we tested whether inhibition of cell cycle-related cyclin-dependent kinases (cdks) can prevent motoneuronal cell death. We showed that three cdk inhibitors, olomoucine, roscovitine and flavopiridol, suppress the death of motoneurons. Finally, we observed early increases in cyclin D1 and cyclin E expression after withdrawal of neurotrophic factors. These findings support the hypothesis that after removal of trophic support, post-mitotic neuronal cells die due to an attempt to re-enter the cell cycle in an uncoordinated and inappropriate manner.
Insights
Neuronal death in conditions like ALS may stem from an aborted attempt by post-mitotic neurons to re-enter the cell cycle. Inhibiting cell cycle kinases protected these neurons, supporting this cell cycle re-entry hypothesis.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Apoptosis in post-mitotic neurons is linked to cell cycle re-entry attempts, evidenced by cyclin expression.
- This cell cycle activation prior to neuronal death is controversial.
- Neuronal loss in disorders like amyotrophic lateral sclerosis (ALS) may involve inappropriate cell cycle re-entry.
Purpose of the Study:
- To investigate the role of cell cycle re-entry in neurotrophic factor withdrawal-induced motoneuron apoptosis.
- To determine if inhibiting cell cycle-dependent kinases (cdks) can prevent motoneuron death.
Main Methods:
- Purified motoneuron cultures were deprived of neurotrophic factors.
- Apoptosis was assessed using DAPI staining, apoptotic microparticle release, and caspase activation.
- The effects of cdk inhibitors (olomoucine, roscovitine, flavopiridol) on motoneuron survival were evaluated.
- Expression of cyclin D1 and cyclin E was monitored.
Main Results:
- Neurotrophic factor withdrawal triggered apoptosis, including nuclear condensation, DNA fragmentation, and apoptotic body formation.
- Apoptotic microparticle release and caspase-3/-9 activation occurred within hours of factor withdrawal.
- CDK inhibitors significantly suppressed motoneuron death.
- Early increases in cyclin D1 and cyclin E expression were observed after factor withdrawal.
Conclusions:
- Motoneuron death induced by trophic factor deprivation involves an inappropriate attempt at cell cycle re-entry.
- Inhibition of cell cycle-dependent kinases offers a protective strategy against this form of neuronal death.
- These findings support the hypothesis that aberrant cell cycle re-entry contributes to neuronal loss in neurodegenerative conditions.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Anaphase Promoting Complex
The Intrinsic Apoptotic Pathway
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules